Holdemanella sp.

Information

Microbe Identification

Holdemanella sp.

Microbe id: PMDBM2021558
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Holdemanella sp. [1971762]
Taxonomy Genus: Holdemanella [1573535]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Holdemanella sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Holdemanella sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Holdemanella sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Holdemanella sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Holdemanella sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Hemangioma, Cavernous PRJNA629755🔗-3.44905293799886mNGS
Hypertension PRJNA509999🔗-3.94096040274586mNGS
Diabetes Mellitus, Type 2 PRJNA588353🔗4.6179181536100716S
Diarrhea PRJEB14038🔗-3.70281798821789mNGS
Diarrhea PRJNA317326🔗-3.5438169039901216S
Colorectal Neoplasms PRJNA936589🔗-3.9428836623518mNGS
Colorectal Neoplasms PRJNA986175🔗-3.6827599017931716S
Gastrointestinal Diseases PRJNA760529🔗-3.3661896446875916S
Mental Disorders PRJNA278793🔗2.4244631365458416S
Colitis, Ulcerative PRJNA398089🔗2.45404363176473mNGS
Spinal Cord Injuries PRJNA669472🔗3.1646847950869116S
Celiac Disease PRJNA890948🔗3.7696790605548516S
Helicobacter Infections PRJDB10599🔗3.5094166697371816S
Caliciviridae Infections PRJNA788674🔗-3.9732098888027316S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-3.7916897425769216S
Hidradenitis Suppurativa PRJEB43835🔗-3.8381560523814216S
Asthma PRJEB59709🔗-3.63590540203799mNGS
Crohn Disease PRJNA813736🔗-3.59822246671953mNGS
Crohn Disease PRJNA820056🔗-3.5541440529235316S
Crohn Disease PRJEB42155🔗-3.35334838673016mNGS
Crohn Disease PRJNA793776🔗-2.92321216594441mNGS
Crohn Disease PRJNA993675🔗2.91554825754755mNGS
Crohn Disease PRJNA1156939🔗3.4447044840721716S
Polycystic Ovary Syndrome PRJNA530971🔗-3.77092592094355mNGS
Polycystic Ovary Syndrome PRJEB38647🔗-3.3544158659144516S
Meningioma PRJNA626591🔗-3.8085443204230716S
Multiple System Atrophy PRJNA532538🔗3.460768007313mNGS
Diabetic Retinopathy PRJNA857030🔗3.6375144246257716S
Arthritis, Rheumatoid PRJNA896336🔗-3.17507787989377mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-2.71850800298962mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-2.67919993426624mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-2.65485474529151mNGS
Cholangiocarcinoma PRJNA932948🔗3.79745046602602mNGS
Flatulence PRJNA206071🔗-2.5188411609500316S
Anorexia Nervosa PRJEB11199🔗2.9711674406584716S
Hepatitis C PRJNA1070593🔗-2.9971807772560916S
Neuroblastoma PRJNA716780🔗3.56452979701253mNGS
Hematologic Neoplasms PRJNA777832🔗-3.852316994190216S
Myasthenia Gravis PRJNA688881🔗3.2514137104594mNGS
Myasthenia Gravis PRJNA450610🔗4.7817528632215816S
Irritable Bowel Syndrome PRJEB37924🔗-3.45672896057764mNGS
Irritable Bowel Syndrome PRJNA682378🔗3.8334184817203916S
IgA Deficiency PRJNA967340🔗3.8169101294965216S
Diabetes, Gestational PRJNA853814🔗-3.38933048660346mNGS
Alzheimer Disease PRJNA770746🔗2.9831603563775216S
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-3.4311010968354216S
Obesity PRJNA1125836🔗3.78362977416772mNGS
HIV Infections PRJDB11949🔗4.2647669134188716S
Autism Spectrum Disorder PRJNA917543🔗-4.0455637753546316S
Hand, Foot and Mouth Disease PRJNA1017976🔗-3.0556390492846616S
Hand, Foot and Mouth Disease PRJNA843173🔗3.4295554809998516S
Renal Insufficiency, Chronic PRJNA659589🔗-3.2258992529097816S
Renal Insufficiency, Chronic PRJNA562327🔗-2.8578064080348916S
Mucocutaneous Lymph Node Syndrome PRJNA595748🔗-2.0869176473298116S
Fibromyalgia PRJEB80379🔗-4.10126947259158mNGS
Breast Neoplasms PRJNA383849🔗-3.4350936345252916S
Breast Neoplasms PRJNA658160🔗2.8652893720181316S
COVID-19 PRJNA769052🔗-3.7451158970593116S
COVID-19 PRJNA624223🔗-3.60060048338358mNGS
COVID-19 PRJNA689961🔗-3.28717511751667mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Holdemanella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Holdemanella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Holdemanella sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Holdemanella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Holdemanella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Holdemanella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Holdemanella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Holdemanella sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Holdemanella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Holdemanella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Holdemanella sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?